Fidelis Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
36,285
-798
| -2% | -$63.4K | 0.26% | 73 |
|
|
2025
Q1 | $3.07M | Sell |
37,083
-9,488
| -20% | -$785K | 0.33% | 65 |
|
|
2024
Q4 | $4.65M | Buy |
46,571
+4,297
| +10% | +$429K | 0.46% | 46 |
|
|
2024
Q3 | $4.5M | Buy |
42,274
+1,298
| +3% | +$138K | 0.54% | 38 |
|
|
2024
Q2 | $4.61M | Buy |
40,976
+2,949
| +8% | +$332K | 0.66% | 30 |
|
|
2024
Q1 | $5.02M | Buy |
38,027
+4,640
| +14% | +$612K | 0.76% | 28 |
|
|
2023
Q4 | $3.64M | Buy |
33,387
+12,534
| +60% | +$1.37M | 0.81% | 24 |
|
|
2023
Q3 | $2.15M | Buy |
20,853
+1,186
| +6% | +$122K | 0.73% | 26 |
|
|
2023
Q2 | $2.27M | Buy |
19,667
+1,325
| +7% | +$153K | 0.83% | 24 |
|
|
2023
Q1 | $2.16M | Buy |
18,342
+7,792
| +74% | +$917K | 0.92% | 19 |
|
|
2022
Q4 | $1.16M | Buy |
+10,550
| New | +$1.16M | 1.37% | 17 |
|